In the pharmaceutical industry, tablets remain the most commonly produced oral dosage form; as such, granulation, which allows primary powder particles to adhere and form granules, is one of the most important unit operations in drug manufacturing.
A number of different granulation and compression technologies are available to pharmaceutical manufacturers, all of which have individual strengths and weaknesses depending on the specific application; however, the theory of granulation is often poorly understood and the selection of a particular machine and granulation method is frequently done on the basis of tradition and the operator’s own experience, rather than by using strict scientific or cost-benefit criteria.
The basic techniques have changed dramatically in recent years and granulation for controlled release, extrusion, spheronization, fluidization techniques, spray drying, melt extrusion, oral dispersion technology and roller compaction are all new technologies that are increasingly being used in modern pharmaceutical production and offer many advantages compared with previously available processes.
In essence, a granulator is a multipurpose processor that’s equally suitable for the high-speed dispersion of dry powders, aqueous or solvent granulations, effervescent products, wet and melt pelletization. At GEA, we supply a complete range of granulation process equipment. With the company’s history of expertise in the market, our reliable legacy of supply, support and manufacturing excellence, you can rest assured that every pharmaceutical plant and system from GEA is a unique union of proven technology and individual solutions.
Offering a wide selection of equipment, modules and systems, our experts are available to provide objective, unbiased advice on the merits and implications of each process and deliver the best solution for your specific granulation application.
Avoid upfront investment and preserve capital. GEA Financial Services offer to you attractive conditions to lease your new GEA equipment. Cost occur over time while the machine is used.
Video support designed to provide remote assistance in real-time.
When a leading manufacturer of generic drug products in Russia with a huge product portfolio wished to expand their reach and integrate some 21st century manufacturing technology, they turned to GEA for help.
The project team at a major pharmaceutical manufacturing company initiated an in-depth feasibility study to assess the capabilities and constraints of ConsiGma®’s technology and process characteristics.
Stay in touch with GEA innovations and stories by signing up for news from GEA.Sign up
We are here to help! With just a few details we will be able to respond to your inquiry.Contact us